Tyrone H.

Tyrone H. is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as a Sickle Cell Therapeutic Specialist at Global Blood Therapeutics since October 2019. Prior experience includes roles such as Institutional Account Manager at Theravance Biopharma US, Inc., where Tyrone launched key products including Yupelri and Vibativ, and Key Account Manager at Turing Pharmaceuticals AG, focusing on the re-launch of Daraprim. Tyrone has also held positions at Medtronic Diabetes, where sales of diabetes therapies were improved, and at AdvanDx, where strategic selling for diagnostic assays was emphasized. Beginning a career at Bristol-Myers Squibb as Senior Territory Business Manager, Tyrone developed effective marketing strategies across multiple therapeutic areas. Educational credentials include a degree in Financial Management/Accounting from Clemson University.